TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Avia Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,456
|
20,248
|
19,523 |
| Financial expenses |
6,529
|
3,499
|
2,736 |
| Earnings before taxes |
-1,310
|
-893
|
1,715 |
| EBITDA |
701
|
1,136
|
2,785 |
| Total assets |
67,806
|
44,878
|
45,210 |
| Current assets |
9,741
|
10,230
|
11,227 |
| Current liabilities |
3,977
|
4,466
|
5,362 |
| Equity capital |
13,748
|
7,934
|
6,153 |
| - share capital |
26
|
27
|
27 |
| Employees (average) |
11
|
8
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.3%
|
17.7%
|
13.6% |
| Turnover per employee |
1,587
|
2,531
|
2,789 |
| Profit as a percentage of turnover |
-7.5%
|
-4.4%
|
8.8% |
| Return on assets (ROA) |
7.7%
|
5.8%
|
9.8% |
| Current ratio |
244.9%
|
229.1%
|
209.4% |
| Return on equity (ROE) |
-9.5%
|
-11.3%
|
27.9% |
| Change turnover |
-2,104
|
668
|
1,710 |
| Change turnover % |
-11%
|
3%
|
10% |
| Chg. No. of employees |
3
|
1
|
1 |
| Chg. No. of employees % |
38%
|
14%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.